Meet the team: Jessica Häfner 🎉 We are delighted to welcome our new Executive Assistant to our Headquarters. Jessica has over 7 years of experience orchestrating schedules for two busy executives in a major consultancy and she has recently joined us as the assistant to our CEO, CFO and CHO 🙂 ✨ Please join us in welcoming Jessica! We are very happy to have her as a part of our team! ✨ #WeAreAdragos #CDMO #MeetTheTeam
Adragos Pharma
Arzneimittelherstellung
Munich, Bavaria 12.290 Follower:innen
A Global CDMO #WeAreAdragos
Info
We are a globally operating Contract Development and Manufacturing Organisation (CDMO) headquartered in Germany. Our sites in Germany, France, Greece and Japan focus on the development and manufacturing of drug products (FDF) in the small molecule segment. Our manufacturing sites cover relevant technologies in sterile liquids, non-sterile liquids, and semi-solids, providing end-to-end services for our large base of (bio)pharma customers. Our development site in Greece is a one-stop shop for our partners offering a range of services to take products from inception to MA grant and supply.
- Website
-
https://www.adragos-pharma.com/
Externer Link zu Adragos Pharma
- Branche
- Arzneimittelherstellung
- Größe
- 501–1.000 Beschäftigte
- Hauptsitz
- Munich, Bavaria
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 2020
- Spezialgebiete
- CDMO, Pharmaceutical Development und Pharmaceutical Manufacturing
Orte
Beschäftigte von Adragos Pharma
-
Stephanie Bova
Chief Digital Officer, NED, R&D Leadership, Digital Tech Start-up Founder/CEO, Commercial Leadership, VC Managing Director,
-
Argyro Stappa
Head of R&D at Lamda Pharmaceuticals Network of companies
-
Henny Zijlstra
CCO of Adragos Pharma, Small Molecules Drug Product CDMO
-
Nicole Fité
Business Development Associate at Adragos Pharma
Updates
-
✈ Only 60 days left to CPHI Milan! 🎉 Meet us on our booth #5D74 on the 8th to 10th of October. We look forward to meeting you there and discussing your needs. Reach out to our team to schedule your meeting. 🤝 #CPHIMilan #CPHI #CDMO #WeAreAdragos
-
🚀 Drug product development With over 70 specialised staff dedicated to innovation and excellence, our #AdragosAthens facility is at the centre of drug development. Our expertise includes a range of technical capabilities that ensure we can meet diverse healthcare needs: ✅ Oral dosage forms ✅ Parenteral dosage forms ✅ Topical dosage forms Learn more here: https://lnkd.in/d-CJrP4t #WeAreAdragos #CDMO #DrugProductDevelopment
-
#AdragosHalden 🌍 As one of Northern Europe's largest and most advanced sterile production facilities, we specialize in producing and distributing IV bags, plastic ampoules, and vials using cutting-edge Blow-Fill-Seal technology. ➡ BFS technology ensures superior sterility, efficiency, and precision, making it a game-changer in pharmaceutical manufacturing. For more information about our innovative BFS technology, visit: https://lnkd.in/dJzazQNB #WeAreAdragos #BFStechnology #sterile #CDMO
-
🌟 Top CDMO Companies Leading 2024: Key Traits and Industry Insights 🌟 🌍 Why choose Adragos? Discover why our global presence, advanced technologies and commitment to regulatory excellence make us a top choice. Click on the link to read more and find the perfect CDMO partner for your pharmaceutical needs: https://lnkd.in/d2Eu9P5B #CDMO #WeAreAdragos #DrugDevelopment #ManufacturingServices #PharmaceuticalIndustry
-
📣 Our Athens facility can help you take your project from Development to Market. Typically, 9 months is required till the first production of registration batches. The time frame for MA grant averages between 12 to18 months. Our Drug Product Development process covers a wide range of industry needs from, advanced formulation, clinical development and analytical services. Find out more about our services here: https://lnkd.in/d-CJrP4t #WeAreAdragos #DrugProductDevelopment #AdragosAthens
-
🌟What makes our Kawagoe facility unique? 🌟 #AdragosKawagoe is our state-of-the-art, end-to-end production facility, offering tablet and ampoule manufacturing. It also offers visual inspection and packaging services to meet Japanese market standards. Learn about its key benefits here 🔽 #CDMO #WeAreAdragos
-
🌐 We are investing in advanced technologies to integrate digitalisation and automation into our manufacturing processes. Real-time data is set to revolutionise our operations, driving excellence in customer service, efficiency, and supply chain performance. We are excited for the journey ahead! 🚀 Read Marco R. Gorgas opinion on the subject ⤵ #WeAreAdragos #Innovation #PharmaExcellence #DigitalFuture #
-
💡 Value Added Medicines and 505(b)(2): Learn what they are, their benefits and submission process 💡 Read our latest article to find out more about these new drug applications: https://lnkd.in/dTdMy3Ke #CDMO #ValueAddedMedicines #505b2 #FDA
Exploring 505b2 Value-Added Medicines: A Complete Overview
https://adragos-pharma.com
-
💡What is the key to building a visionary company? Find our CEO's, Dr. Andreas Raabe, inspiring thoughts on the vision he wanted to create with Adragos in this video ⤵ #WeAreAdragos #CDMO #Vision #VisionaryCompany